US20030109680A1 - Antibodies for inhibiting blood coagulation and methods of use thereof - Google Patents

Antibodies for inhibiting blood coagulation and methods of use thereof Download PDF

Info

Publication number
US20030109680A1
US20030109680A1 US09/990,586 US99058601A US2003109680A1 US 20030109680 A1 US20030109680 A1 US 20030109680A1 US 99058601 A US99058601 A US 99058601A US 2003109680 A1 US2003109680 A1 US 2003109680A1
Authority
US
United States
Prior art keywords
amino acid
seq id
acid sequence
antibody
identical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/990,586
Inventor
Hing Wong
Jin-An Jiao
Esperanza Nieves
Lawrence Luepschen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Sunol Molecular Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunol Molecular Corp filed Critical Sunol Molecular Corp
Priority to US09/990,586 priority Critical patent/US20030109680A1/en
Priority claimed from US10/230,880 external-priority patent/US20030190705A1/en
Priority claimed from TW91125173A external-priority patent/TWI338009B/en
Assigned to SUNOL MOLECULAR CORPORATION reassignment SUNOL MOLECULAR CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NIEVES, ESPERANZA LILIANA
Assigned to SUNOL MOLECULAR CORPORATION reassignment SUNOL MOLECULAR CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JIAO, JIN-AN, MOSQUERA, LUIS A., WONG, HING C.
Priority claimed from US10/310,113 external-priority patent/US20060235209A9/en
Publication of US20030109680A1 publication Critical patent/US20030109680A1/en
Assigned to TANOX, INC. reassignment TANOX, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SUNOL MOLECULAR CORPORATION
Assigned to GENENTECH, INC. reassignment GENENTECH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TANOX, INC.
Priority claimed from AU2008203271A external-priority patent/AU2008203271B2/en
Application status is Abandoned legal-status Critical

Links